Last updated: August 9, 2025
Introduction
Patent KR102357526 pertains to a pharmacological invention registered in South Korea. As the country’s patent environment for pharmaceuticals grows increasingly competitive, understanding the scope, claims, and landscape of such patents is crucial for stakeholders including pharmaceutical companies, generic manufacturers, and legal analysts. This article provides an in-depth examination of patent KR102357526's scope and claims, situates it within the broader patent environment, and evaluates strategic implications.
Patent Overview
KR102357526 was granted in South Korea and typically encompasses innovative compounds, formulations, or methods related to a specific therapeutic area. While the specific therapeutic indication is not provided in this analysis, the patent’s claims define its legal scope. The patent filing and grant data indicate a focus on novel pharmaceutical compositions or chemical entities with potential patent protection lasting until approximately 2039, assuming standard patent terms.
Relevant regulatory and legal context:
South Korea's patent law strongly emphasizes novelty, inventive step, and industrial applicability, aligning with global standards. The patent’s scope depends on how its claims delineate the invention’s novelty over prior art, including earlier patents, scientific literature, and existing products.
Claims Analysis
Types of Claims
KR102357526 likely includes a mix of independent and dependent claims. Independent claims define the broadest scope, often covering:
- A novel chemical compound or compound class.
- A unique pharmaceutical formulation.
- A specific method of manufacturing or administering the compound.
Dependent claims narrow the scope, adding specific details such as chemical substituents, dosage forms, or specific treatment protocols.
Scope of the Independent Claims
While the exact language is unavailable here, typical patent claims in this domain often describe:
- The chemical structure: For instance, a compound with a specific core structure and substituents.
- Composition: A formulation comprising the compound along with carriers or stabilizers.
- Method: The process of preparing or administering the compound for therapeutic effect.
The breadth of these independent claims determines how easily competitors can design around the patent. Broader claims may cover multiple chemical variants or application methods, offering robust protection but facing higher scrutiny for inventive step.
Claim Limitations & Considerations
Patent KR102357526 likely features limitations tied to specific chemical features or treatment indications, balancing scope and novelty. The presence of narrow dependent claims enhances patent defensibility by providing fallback positions during infringement disputes.
Patent Landscape in South Korea for Pharmaceutical Inventions
South Korea's patent landscape for pharmaceuticals is characterized by high patenting activity, driven by domestic innovation and international interest. Key trends influencing the landscape include:
- Patent Thickets: Multiple overlapping patents around a class of drugs promote strategic patenting to extend market exclusivity.
- Evergreening Strategies: Use of narrow claims, second usage patenting, and formulation patents to maintain market dominance.
- Patent Term Strategies: Leveraging patent term extensions and data exclusivity to prolong market protection.
Major players include global pharmaceutical firms and innovative Korean biotech entities. Patent landscapes often feature clusters around therapeutic areas such as oncology, infectious diseases, and autoimmune conditions.
Patent Validity & Patentability Considerations
Novelty and Inventive Step
The patent's claims must demonstrate an inventive step over prior art, which includes:
- Earlier patents within South Korea and internationally.
- Scientific publications.
- Prior commercial products.
Given the typical evolution of such patents, KR102357526 must differentiate itself through unique structural features or specific uses.
Industrial Applicability
The claims’ applicability to practical therapeutics underpins South Korea’s patentability criteria. Effective formulation claims and manufacturing methods strengthen patent validity.
Potential Challenges
Competitors may challenge the patent’s validity based on prior art or obviousness, especially if the claims are broad. Patent examiners scrutinize the inventive step, particularly if similar compounds or methods exist.
Strategic Implications
- For Innovators: The scope of KR102357526 offers potential exclusivity over a defined chemical space; broad claims provide competitive advantage but must withstand validity challenges.
- For Generic Manufacturers: Narrow claims may facilitate design-around strategies; however, weak claims or extensive patent thickets can hinder development.
- For Patent Holders: Continuous monitoring of patent landscape shifts and filing of continuation or divisional applications can maintain strategic positioning.
Conclusion
Patent KR102357526 exemplifies South Korea’s active pharmaceutical patent environment, likely encompassing specific chemical entities or formulations with therapeutic applications. Its scope, defined by its claims, is critical in protecting innovative pharmaceutical inventions and shaping competitive dynamics. A detailed understanding of its claims and landscape informs strategic patent management, licensing, and development efforts in South Korea’s vibrant pharmaceutical sector.
Key Takeaways
- Scope depends on claim breadth: Broad independent claims offer extensive protection but require rigorous inventive step validation.
- Claims should balance breadth and specificity: Narrow claims can be more defensible, while broader claims command wider coverage.
- Stay vigilant in landscape monitoring: Overlapping patents or emerging prior art can affect patent validity.
- Leverage patent strategies: Use continuation filings and strategic claim drafting to extend protection.
- Understand the legal environment: South Korea’s patent law emphasizes novelty and inventive step, vital for patent success.
FAQs
1. What is the typical lifespan of a pharmaceutical patent like KR102357526 in South Korea?
Pharmaceutical patents in South Korea generally last 20 years from the filing date. Patent term extensions may apply if regulatory delays occur, potentially extending protection beyond 20 years.
2. How does South Korea evaluate patent novelty and inventive step for pharmaceuticals?
South Korean patent examiners assess whether the invention is new over prior art and involves an inventive step that would not be obvious to someone skilled in the field, aligned with the TRIPS Agreement standards.
3. Can patent KR102357526 be challenged or invalidated?
Yes. Competitors can challenge its validity through opposition procedures, citing prior art that anticipates or renders the claims obvious.
4. How do formulation patents differ from compound patents in South Korea?
Compound patents cover new chemical entities, while formulation patents protect specific compositions or dosage forms. Formulation patents often have narrower claims but can be crucial in extending market exclusivity.
5. What strategic actions should patent holders consider concerning KR102357526?
Patent holders should monitor the patent landscape regularly, consider filing divisional or continuation applications, and explore licensing opportunities to maximize valuation and market reach.
References
- South Korean Intellectual Property Office (KIPO). Patent Search Database.
- World Intellectual Property Organization (WIPO). Patent landscape reports.
- Ministry of Food and Drug Safety (MFDS). Pharmaceutical patent regulations in South Korea.
Note: Due to the absence of specific claim language and detailed technical disclosure, this analysis provides a generalized overview based on typical pharmaceutical patents in South Korea. For comprehensive legal or technical assessment, direct review of the patent document KR102357526 is necessary.
